At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- GLP-1s linked to better IBD outcomes, hinting at role as ‘valuable adjunctive therapies’ (Healio)
- The cyber siege of private practices: Are you at risk? (Medical Economics)
- Is The Galleri Cancer Test Worth It? A Doctor Explains (Forbes)
- With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists (GI & Hepatology News)
- The GI innovations transforming outcomes (Becker’s GI & Endoscopy)
- The Smart Toilet: Turning Waste Into Health Insights – Dr. Sonia Grego, Ph.D. (Progress, Potential, and Possibilities | YouTube)
- Peripheral gaze guidance improves adenoma detection rate (GI & Hepatology News)
- Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus (American Journal of Gastroenterology)
